Expert Reports Increase in Early-Onset Cancer Due to Breast/Gyn Malignancies

Commentary
Video

Data from a study highlight that the breast cancer makes up the highest number of early-onset disease cases compared with other cancer types from 2010 to 2019, although overall cancer morality appears to have decreased.

Data from a study exploring a rise in early-onset cancer incidence from 2010 to 2019 indicated that breast cancer was particularly prevalent, according to Monique Gary, DO MSc, FACS, in a conversation with CancerNetwork®.

Findings from the study indicated that the number of female patients with early-onset cancer increased from 34,233 in 2010 to 35,721, representing an increase of 4.35% over this period. Moreover, while investigators observed the highest total of early-onset disease cases in the breast cancer population, Gary, a breast surgeon and medical director at Grand View Health, noted that overall cancer mortality appeared to decrease, which warrants additional research.

Data from the study also highlighted that 12,649 patients were diagnosed with early-onset breast cancer in 2019, which was the highest incidence of early-onset disease compared with other cancer types in that year. Additionally, investigators observed that early-onset breast cancer cases increased by 7.70% from 2010 to 2019.

Transcript:

The study looked at over 500,000 individuals from 2010 to 2019. What they found was that the increase in cancer in younger individuals is being driven by cancers in women and adults in their 30s. When we say cancer in women, we particularly [mean] breast and gynecologic cancers like uterine cancers. There were 34,233, early-onset cancers in women in 2010 and 35,721 in 2019; that increase was about 4.35% or so. While breast cancer showed the highest total of all the cases among the early onset [population], it’s an interesting juxtaposition because we’re also noting that there’s a decrease in overall cancer mortality. That’s something that we need to look into a little bit further.

Reference

Koh B, Hao Tan DJ, Ng HN, et al. Patterns in cancer incidence among people younger than 50 years in the US, 2010 to 2019. JAMA Netw Open. 2023;6(8):e2328171. doi:10.1001/jamanetworkopen.2023.28171

Recent Videos
An 80% sensitivity for lung cancer was observed with the liquid biopsy, with high sensitivity observed for early-stage disease, as well.
Harmonizing protocols across the health care system may bolster the feasibility of giving bispecifics to those with lymphoma in a community setting.
Patients who face smoking stigma, perceive a lack of insurance, or have other low-dose CT related concerns may benefit from blood testing for lung cancer.
Establishment of an AYA Lymphoma Consortium has facilitated a process to better understand and address gaps in knowledge for this patient group.
Adult and pediatric oncology collaboration in assessing nivolumab in advanced Hodgkin lymphoma facilitated the phase 3 SWOG S1826 findings.
Treatment paradigms differ between adult and pediatric oncologists when treating young adults with lymphoma.
Differences in pancreatic cancer responses to treatment elicits a need to better educate patients on expectations in treatment, particularly chemotherapy.
Increasing patient awareness of modifiable risk factors for pancreatic cancer may help mitigate incidence of pancreatic cancers.
It may be crucial to test every patient for markers such as BRAF V600E mutations, NRG1 fusions, and KRAS G12C mutations to help manage pancreatic cancers.
Tanios S. Bekaii-Saab, MD, emphasizes the idea of moving targeted therapies to earlier lines of treatment to further improve outcomes in pancreatic cancer.